CLRB / Cellectar Biosciences, Inc. - Net Long/Short Value

Cellectar Biosciences, Inc.
US ˙ NasdaqCM ˙ US15117F8077

CLRB / Cellectar Biosciences, Inc. - Net Long/Short Value
Halaman ini menyediakan penilaian bersih long/short untuk setiap pegangan institusi yang dilaporkan melalui pemfailan 13F atau NPORT. Untuk mengira nilai bersih long/short, kami menambah nilai ekuiti pada nilai opsyen beli dan menolak nilai opsyen jual. Dana yang melaporkan kedudukan pinjaman jual singkat akan melaporkan nilai ekuiti sebagai negatif. Posisi beli bersih akan mempunyai nombor positif dalam lajur bersih long/short, dan posisi singkat jual bersih akan mempunyai nilai negatif dalam lajur tersebut.
Pemilik Nilai Ekuiti
($1000)
Nilai Call
($1000)
Nilai Put
($1000)
Long/Short Bersih
($1000)
FSMAX - FIDELITY CONCORD STREET TRUST - Fidelity Extended Market Index Fund
FNCMX - FIDELITY CONCORD STREET TRUST - Fidelity Nasdaq Composite Index Fund
Bank Of America Corp /de/
Simplex Trading, Llc
Citigroup Inc
Group One Trading, L.p.
Morgan Stanley
UBS Group AG
FSKAX - FIDELITY CONCORD STREET TRUST - Fidelity Total Market Index Fund
Harbour Investments, Inc.
Vanguard Group Inc
SBI Securities Co., Ltd.
Hrt Financial Lp
Jones Financial Companies Lllp
BlackRock, Inc.
Us Bancorp \de\
Advisor Group Holdings, Inc.
VEXMX - VANGUARD INDEX FUNDS - Vanguard Extended Market Index Fund Investor Shares
Geode Capital Management, Llc
FCFMX - FIDELITY CONCORD STREET TRUST - Fidelity Series Total Market Index Fund
Riverview Capital Advisers, LLC
Tower Research Capital LLC (TRC)
VBINX - Vanguard Valley Forge Funds - Vanguard Balanced Index Fund Investor Shares
Raymond James Financial Inc
VTSMX - VANGUARD INDEX FUNDS - Vanguard Total Stock Market Index Fund Investor Shares
Other Listings
DE:NV40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista